4//SEC Filing
BOWLIN MICHAEL R 4
Accession 0001225208-13-005782
CIK 0001099800other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:28 PM ET
Size
8.6 KB
Accession
0001225208-13-005782
Insider Transaction Report
Form 4
BOWLIN MICHAEL R
Director
Transactions
- Exercise/Conversion
Common Stock
2013-02-26$22.71/sh+3,520$79,957→ 77,908 total - Sale
Common Stock
2013-02-26$87.09/sh−3,520$306,557→ 74,388 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2013-02-26−3,520→ 0 totalExercise: $22.71From: 2006-07-03Exp: 2013-07-12→ Common Stock (3,520 underlying)
Footnotes (2)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $87.01 to $87.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001192506
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:28 PM ET
- Size
- 8.6 KB